{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:22:14Z","timestamp":1790392934924,"version":"4.1.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","funder":[{"name":"Intramural Research Program of the Center for Drug Evaluation and Research"},{"DOI":"10.13039\/100009210","name":"Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Fellowship Program for Center for Drug Evaluation and Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/intimm\/dxy052","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T19:22:34Z","timestamp":1533928954000},"source":"Crossref","is-referenced-by-count":10,"title":["CD21 and FCRL5 form a receptor complex with robust B-cell activating capacity"],"prefix":"10.1093","author":[{"given":"Andrea","family":"Franco","sequence":"first","affiliation":[{"name":"Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Kraus","sequence":"additional","affiliation":[{"name":"Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Li","sequence":"additional","affiliation":[{"name":"Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Seibert","sequence":"additional","affiliation":[{"name":"Fina Biosolutions LLC, Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Dement-Brown","sequence":"additional","affiliation":[{"name":"Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mate","family":"Tolnay","sequence":"additional","affiliation":[{"name":"Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,11]]},"reference":[{"key":"key\n\t\t\t\t20180906100257_CIT0001","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1074-7613(00)80418-5","article-title":"The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity","volume":"6","author":"Tedder","year":"1997","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20180906100257_CIT0002","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.immuni.2012.08.002","article-title":"Regulation of humoral immunity by complement","volume":"37","author":"Carroll","year":"2012","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20180906100257_CIT0003","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1084\/jem.173.1.55","article-title":"Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19","volume":"173","author":"Matsumoto","year":"1991","journal-title":"J. Exp. Med"},{"key":"key\n\t\t\t\t20180906100257_CIT0004","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1073\/pnas.81.14.4510","article-title":"Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2","volume":"81","author":"Fingeroth","year":"1984","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20180906100257_CIT0005","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/j.1460-2075.1991.tb08025.x","article-title":"Epstein Barr virus\/complement C3d receptor is an interferon alpha receptor","volume":"10","author":"Delcayre","year":"1991","journal-title":"EMBO J"},{"key":"key\n\t\t\t\t20180906100257_CIT0006","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/358505a0","article-title":"CD21 is a ligand for CD23 and regulates IgE production","volume":"358","author":"Aubry","year":"1992","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180906100257_CIT0007","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.4049\/jimmunol.159.8.3782","article-title":"The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CR2)","volume":"159","author":"Mongini","year":"1997","journal-title":"J. Immunol"},{"key":"key\n\t\t\t\t20180906100257_CIT0008","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/clin.1998.4552","article-title":"Complement receptor 2 in the regulation of the immune response","volume":"88","author":"Tolnay","year":"1998","journal-title":"Clin. Immunol. Immunopathol"},{"key":"key\n\t\t\t\t20180906100257_CIT0009","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.molimm.2010.12.019","article-title":"Human complement receptor type 2 (CR2\/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists","volume":"48","author":"Kulik","year":"2011","journal-title":"Mol. Immunol"},{"key":"key\n\t\t\t\t20180906100257_CIT0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1373518","article-title":"CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes","volume":"256","author":"Carter","year":"1992","journal-title":"Science"},{"key":"key\n\t\t\t\t20180906100257_CIT0011","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.271.5247.348","article-title":"C3d of complement as a molecular adjuvant: bridging innate and acquired immunity","volume":"271","author":"Dempsey","year":"1996","journal-title":"Science"},{"key":"key\n\t\t\t\t20180906100257_CIT0012","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/1521-4141(200003)30:3<969::AID-IMMU969>3.0.CO;2-A","article-title":"Enhanced and sustained activation of human B cells by anti-immunoglobulin conjugated to the EBV glycoprotein gp350","volume":"30","author":"Goeckeritz","year":"2000","journal-title":"Eur. J. Immunol"},{"key":"key\n\t\t\t\t20180906100257_CIT0013","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.4049\/jimmunol.172.12.7556","article-title":"Binding of cytoplasmic proteins to the CD19 intracellular domain is high affinity, competitive, and multimeric","volume":"172","author":"Brooks","year":"2004","journal-title":"J. Immunol"},{"key":"key\n\t\t\t\t20180906100257_CIT0014","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1074-7613(00)80094-1","article-title":"Modulation of B lymphocyte antigen receptor signal transduction by a CD19\/CD22 regulatory loop","volume":"11","author":"Fujimoto","year":"1999","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20180906100257_CIT0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni1547","article-title":"CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand","volume":"9","author":"Depoil","year":"2008","journal-title":"Nat. Immunol"},{"key":"key\n\t\t\t\t20180906100257_CIT0016","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1146\/annurev.immunol.25.022106.141541","article-title":"Fc receptor-like molecules","volume":"25","author":"Davis","year":"2007","journal-title":"Annu. Rev. Immunol"},{"key":"key\n\t\t\t\t20180906100257_CIT0017","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/intimm\/dxl069","article-title":"Expression pattern of the human FcRH\/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia","volume":"18","author":"Polson","year":"2006","journal-title":"Int. Immunol"},{"key":"key\n\t\t\t\t20180906100257_CIT0018","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1074-7613(01)00109-1","article-title":"IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy","volume":"14","author":"Hatzivassiliou","year":"2001","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20180906100257_CIT0019","doi-asserted-by":"crossref","first-page":"9772","DOI":"10.1073\/pnas.171308498","article-title":"Identification of a family of Fc receptor homologs with preferential B cell expression","volume":"98","author":"Davis","year":"2001","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20180906100257_CIT0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4049\/jimmunol.1000832","article-title":"Cutting edge: FcR-like 6 is an MHC class II receptor","volume":"185","author":"Schreeder","year":"2010","journal-title":"J. Immunol"},{"key":"key\n\t\t\t\t20180906100257_CIT0021","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.4049\/jimmunol.1102651","article-title":"Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG","volume":"188","author":"Wilson","year":"2012","journal-title":"J. Immunol"},{"key":"key\n\t\t\t\t20180906100257_CIT0022","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.4049\/jimmunol.1202860","article-title":"Human Fc receptor-like 5 binds intact IgG via mechanisms distinct from those of Fc receptors","volume":"190","author":"Franco","year":"2013","journal-title":"J. Immunol"},{"key":"key\n\t\t\t\t20180906100257_CIT0023","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.1073\/pnas.0703354104","article-title":"Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment","volume":"104","author":"Haga","year":"2007","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20180906100257_CIT0024","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.molimm.2017.10.020","article-title":"Human Fc receptor-like 5 distinguishes IgG2 disulfide isoforms and deamidated charge variants","volume":"92","author":"Alabi","year":"2017","journal-title":"Mol. Immunol"},{"key":"key\n\t\t\t\t20180906100257_CIT0025","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.4049\/jimmunol.1501027","article-title":"Fc receptor-like 5 expression distinguishes two distinct subsets of human circulating tissue-like memory B cells","volume":"196","author":"Li","year":"2016","journal-title":"J. Immunol"},{"key":"key\n\t\t\t\t20180906100257_CIT0026","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1158\/1078-0432.87.11.1","article-title":"Immunoglobulin superfamily receptor translocation associated 2 protein on lymphoma cell lines and hairy cell leukemia cells detected by novel monoclonal antibodies","volume":"11","author":"Ise","year":"2005","journal-title":"Clin. Cancer Res"},{"key":"key\n\t\t\t\t20180906100257_CIT0027","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.leu.2404445","article-title":"Elevation of soluble CD307 (IRTA2\/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma","volume":"21","author":"Ise","year":"2007","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180906100257_CIT0028","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1189\/jlb.0211096","article-title":"Fc receptor-like 5 promotes B cell proliferation and drives the development of cells displaying switched isotypes","volume":"91","author":"Dement-Brown","year":"2012","journal-title":"J. Leukoc. Biol"},{"key":"key\n\t\t\t\t20180906100257_CIT0029","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.175.5.1367","article-title":"Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens","volume":"175","author":"Snapper","year":"1992","journal-title":"J. Exp. Med"},{"key":"key\n\t\t\t\t20180906100257_CIT0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cellimm.2005.08.002","article-title":"Characterization of antibodies submitted to the B cell section of the 8th Human Leukocyte Differentiation Antigens Workshop by flow cytometry and immunohistochemistry","volume":"236","author":"Vidal-Laliena","year":"2005","journal-title":"Cell. Immunol"},{"key":"key\n\t\t\t\t20180906100257_CIT0031","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.immuni.2009.12.005","article-title":"The membrane skeleton controls diffusion dynamics and signaling through the B cell receptor","volume":"32","author":"Treanor","year":"2010","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20180906100257_CIT0032","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1084\/jem.20101125","article-title":"Dynamic cortical actin remodeling by ERM proteins controls BCR microcluster organization and integrity","volume":"208","author":"Treanor","year":"2011","journal-title":"J. Exp. Med"},{"key":"key\n\t\t\t\t20180906100257_CIT0033","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.immuni.2012.11.019","article-title":"The actin and tetraspanin networks organize receptor nanoclusters to regulate B cell receptor-mediated signaling","volume":"38","author":"Mattila","year":"2013","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20180906100257_CIT0034","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.4049\/jimmunol.164.6.3123","article-title":"Systematic analysis of the role of CD19 cytoplasmic tyrosines in enhancement of activation in Daudi human B cells: clustering of phospholipase C and Vav and of Grb2 and Sos with different CD19 tyrosines","volume":"164","author":"Brooks","year":"2000","journal-title":"J. Immunol"},{"key":"key\n\t\t\t\t20180906100257_CIT0035","doi-asserted-by":"crossref","first-page":"32514","DOI":"10.1016\/S0021-9258(18)31664-8","article-title":"Signaling through CD19 activates Vav\/mitogen-activated protein kinase pathway and induces formation of a CD19\/Vav\/phosphatidylinositol 3-kinase complex in human B cell precursors","volume":"269","author":"Weng","year":"1994","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20180906100257_CIT0036","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1002\/eji.1830251040","article-title":"Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains","volume":"25","author":"Chalupny","year":"1995","journal-title":"Eur. J. Immunol"},{"key":"key\n\t\t\t\t20180906100257_CIT0037","doi-asserted-by":"crossref","first-page":"37651","DOI":"10.1074\/jbc.M311985200","article-title":"Tec kinases mediate sustained calcium influx via site-specific tyrosine phosphorylation of the phospholipase Cgamma Src homology 2-Src homology 3 linker","volume":"279","author":"Humphries","year":"2004","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20180906100257_CIT0038","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0092-8674(93)90667-F","article-title":"Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia","volume":"72","author":"Tsukada","year":"1993","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180906100257_CIT0039","doi-asserted-by":"crossref","first-page":"9986","DOI":"10.1128\/MCB.24.22.9986-9999.2004","article-title":"Mechanism of B-cell receptor-induced phosphorylation and activation of phospholipase C-gamma2","volume":"24","author":"Kim","year":"2004","journal-title":"Mol. Cell. Biol"},{"key":"key\n\t\t\t\t20180906100257_CIT0040","doi-asserted-by":"crossref","first-page":"E1282","DOI":"10.1073\/pnas.1215156110","article-title":"FCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling","volume":"110","author":"Zhu","year":"2013","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20180906100257_CIT0041","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.07218","article-title":"Malaria-associated atypical memory B cells exhibit markedly reduced B cell receptor signaling and effector function","volume":"4","author":"Portugal","year":"2015","journal-title":"Elife"}],"container-title":["International Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/intimm\/advance-article-pdf\/doi\/10.1093\/intimm\/dxy052\/25692082\/dxy052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T08:47:29Z","timestamp":1693817249000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/intimm\/advance-article\/doi\/10.1093\/intimm\/dxy052\/5070491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,11]]},"references-count":41,"URL":"https:\/\/doi.org\/10.1093\/intimm\/dxy052","relation":{},"ISSN":["0953-8178","1460-2377"],"issn-type":[{"value":"0953-8178","type":"print"},{"value":"1460-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,11]]}}}